Novel genomic prognostic factors for nonsurgical esophageal squamous cell carcinoma treated with concurrent chemoradiotherapy.

被引：0
|
作者：
Dai, Honghai
Shao, Yang
Tong, Xiaoling
Wu, Xue
Pang, Jiaohui
Feng, Alei
Yang, Zhe
机构：
[1] Shandong Univ, Shandong Prov Hosp, Tumor Res & Therapy Ctr, Jinan, Shandong, Peoples R China
[2] Nanjing Med Univ, Sch Publ Hlth, Nanjing, Jiangsu, Peoples R China
[3] Geneseeq Technol Inc, Toronto, ON, Canada
[4] Geneseeq Technol Inc, Translat Med Res Inst, Toronto, ON, Canada
[5] Nanjing Geneseeq Technol Inc, Nanjing, Jiangsu, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.e15589
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15589
引用
收藏
页数：1
相关论文
共 50 条
  • [41] The prognostic significance of perineural invasion in patients with esophageal adenocarcinoma treated with neoadjuvant chemoradiotherapy.
    Patel, Ankur Kaushik
    Pan, Xueliang Jeff
    Williams, Terence M.
    Wuthrick, Evan John
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [42] Chemoradiotherapy for squamous cell anal carcinoma: a review of prognostic factors
    Kapacee, Z. A.
    Susnerwala, S.
    Wise, M.
    Biswas, A.
    Danwata, F.
    Scott, N.
    COLORECTAL DISEASE, 2016, 18 (11) : 1080 - 1086
  • [43] Molecular prognostic factors in esophageal squamous cell carcinoma
    Nita, ME
    Nagawa, H
    Tominaga, O
    Tsuno, N
    Muto, T
    Dias, LAN
    Valladares, G
    Kato, M
    Domene, CE
    17TH INTERNATIONAL CANCER CONGRESS, VOL 1 AND 2, 1998, : 875 - 878
  • [44] Inflammatory prognostic factors in advanced or recurrent esophageal squamous cell carcinoma treated with nivolumab
    Tatsuki Ikoma
    Mototsugu Shimokawa
    Toshihiko Matsumoto
    Shogen Boku
    Tomoyo Yasuda
    Nobuhiro Shibata
    Yusuke Kurioka
    Masahiro Takatani
    Tetsuji Nobuhisa
    Tsutomu Namikawa
    Hiroyuki Kitagawa
    Kazuhiro Hanazaki
    Keitaro Doi
    Takanobu Shimada
    Takehiko Tsumura
    Hiroyuki Marusawa
    Seichiro Kanaya
    Shuko Morita
    Tetsurou Inokuma
    Hiroki Nagai
    Hisateru Yasui
    Hironaga Satake
    Cancer Immunology, Immunotherapy, 2023, 72 : 427 - 435
  • [45] Inflammatory prognostic factors in advanced or recurrent esophageal squamous cell carcinoma treated with nivolumab
    Ikoma, Tatsuki
    Shimokawa, Mototsugu
    Matsumoto, Toshihiko
    Boku, Shogen
    Yasuda, Tomoyo
    Shibata, Nobuhiro
    Kurioka, Yusuke
    Takatani, Masahiro
    Nobuhisa, Tetsuji
    Namikawa, Tsutomu
    Kitagawa, Hiroyuki
    Hanazaki, Kazuhiro
    Doi, Keitaro
    Shimada, Takanobu
    Tsumura, Takehiko
    Marusawa, Hiroyuki
    Kanaya, Seichiro
    Morita, Shuko
    Inokuma, Tetsurou
    Nagai, Hiroki
    Yasui, Hisateru
    Satake, Hironaga
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (02) : 427 - 435
  • [46] Prognostic factors in esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiation therapy
    Okumura, Hiroshi
    Uchikado, Yasuto
    Matsumoto, Masataka
    Owaki, Tetsuhiro
    Kita, Yoshiaki
    Omoto, Itaru
    Sasaki, Ken
    Sakurai, Toshihide
    Setoyama, Tetsuro
    Nabeki, Bunpei
    Matsushita, Daisuke
    Ishigami, Sumiya
    Hiraki, Yoshiyuki
    Nakajo, Masayuki
    Natsugoe, Shoji
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2013, 18 (02) : 329 - 334
  • [47] Prognostic factors in esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiation therapy
    Hiroshi Okumura
    Yasuto Uchikado
    Masataka Matsumoto
    Tetsuhiro Owaki
    Yoshiaki Kita
    Itaru Omoto
    Ken Sasaki
    Toshihide Sakurai
    Tetsuro Setoyama
    Bunpei Nabeki
    Daisuke Matsushita
    Sumiya Ishigami
    Yoshiyuki Hiraki
    Masayuki Nakajo
    Shoji Natsugoe
    International Journal of Clinical Oncology, 2013, 18 : 329 - 334
  • [48] Genomic characteristics in neoadjuvant chemoradiotherapy for locally advanced esophageal squamous cell carcinoma
    He, Wenwu
    Leng, Xuefeng
    Wang, Kangning
    Mao, Tiaoqin
    Peng, Lin
    Fang, Qiang
    Xiao, Wenguang
    Han, Yongtao
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2020, 11 (06) : 1105 - 1112
  • [49] Evaluation of prognostic factors of esophageal squamous cell carcinoma (stage II-III) after concurrent chemoradiotherapy (CRT) using biopsy specimens
    Takayuki, K.
    Hiroya, T.
    Shinichiro, K.
    Masahiro, G.
    Shunsuke, O.
    Shin, K.
    Ken-ichi, K.
    ANNALS OF ONCOLOGY, 2007, 18 : VII91 - VII91
  • [50] Prognostic Factors of Salvage Esophagectomy for Residual or Recurrent Esophageal Squamous Cell Carcinoma After Definitive Chemoradiotherapy
    Yuki Kiyozumi
    Naoya Yoshida
    Takatsugu Ishimoto
    Taisuke Yagi
    Yuki Koga
    Tomoyuki Uchihara
    Hiroshi Sawayama
    Yukiharu Hiyoshi
    Masaaki Iwatsuki
    Yoshifumi Baba
    Yuji Miyamoto
    Masayuki Watanabe
    Tomohiko Matsuyama
    Natsuo Oya
    Hideo Baba
    World Journal of Surgery, 2018, 42 : 2887 - 2893
12345